Director/PDMR Shareholding

Rhea-AI Summary

Amryt Pharma plc announced a transaction involving shares by its Chairman, Ray Stafford. On November 29, 2021, Stafford purchased 50,000 ADSs at a price of $9.40 each, totaling $470,000. This transaction was reported in compliance with the EU Market Abuse Regulation. The shares were purchased on the NASDAQ.

Positive

• Chairman Ray Stafford purchased 50,000 ADSs at $9.40 each, indicating confidence in the company.

Negative

• None.

Amryt Pharma plc

Director/PDMR Shareholding

The following notification is made in accordance with the requirements of the EU Market Abuse Regulation (as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018).

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

1
Details of the person discharging managerial responsibilities/person closely associated

a)
Name

Ray Stafford

2
Reason for the notification

a)
Position/status

Chairman

b)
Initial Notification Amendment

Initial Notification

  
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Amryt Pharma plc

b)
LEI
213800YNUJEOJ8L4T95

4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial  instrument, 
type  of
instrument
Identification code
American Depositary Shares

US03217L1061

b)
Nature of the transaction   

Purchase of Shares

c)
Price(s) and volume(s)

Price(s)	Volume(s)
$9.40	50,000 ADSs

d)
Aggregated information
— Aggregated volume
— Price

N/A – single transaction

e)
Date of the transaction

November 29, 2021

f)
Place of the transaction

NASDAQ

Contacts Joe Wiley, CEO / Rory Nealon, CFO/COO, +353 (1) 518 0200, ir@amrytpharma.com Daniel Bush, Shore Capital, NOMAD, +44 (0) 207 408 4090, amrytcorproate@shorecap.co.uk Tim McCarthy, LifeSci Advisors, LLC, +1 (212) 915 2564, tim@lifesciadvisors.com Amber Fennell, Consilium Strategic Communications, +44 (0) 203 709 5700, fennell@consilium-comms.com

FAQ

What shares did Amryt Pharma's Chairman purchase?

On November 29, 2021, Chairman Ray Stafford purchased 50,000 American Depositary Shares (ADSs) at a price of $9.40 each.

When did the share purchase by Ray Stafford occur?

The share purchase occurred on November 29, 2021.

What was the price per share for the ADSs purchased by Amryt Pharma's Chairman?

The price per share for the ADSs purchased was $9.40.

Where were the shares purchased by Ray Stafford transacted?

The shares were purchased on the NASDAQ.

What is the significance of the share purchase announcement by Amryt Pharma?

The share purchase by Chairman Ray Stafford may indicate his confidence in the company's future performance.